ArticleThe Journal of clinical investigation2022

Losartan ameliorates TGF-β1-induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies.

Michael D Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.